Last reviewed · How we verify
NCT04035681
Problem-Solving Therapy for Depressive Symptoms and Quality of Life in Stroke Survivor-Caregiver Dyads
NA trial testing Problem-Solving Therapy in Stroke in 28 participants. Completed in 22 July 2020.
2 June 2020
Quick facts
| Lead sponsor | Allina Health System |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 28 |
| Start date | 10 June 2019 |
| Primary completion | 2 June 2020 |
| Estimated completion | 22 July 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Problem-Solving Therapy
- Stroke-Related Health Education
Conditions studied
- Stroke — all drugs for Stroke →
- Quality of Life — all drugs for Quality of Life →
- Depression — all drugs for Depression →
Sponsor
Allina Health System — full company profile →
Who can join
Adults 18 to 70, any sex, with Stroke or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this feasibility study is to determine whether it is practical and helpful to provide problem-solving therapy to stroke survivors and their spouses/partners (caregivers) together. It will also compare the experiences of participants who receive problem-solving therapy to those who receive stroke-related health education. Many stroke survivors and caregivers report feeling sad or blue at some point after the stroke. These feelings can impact quality of life. Encountering problems is a part of daily life. These problems can be big or small, but sometimes they can pile up and feel overwhelming, contributing to feelings of sadness. Problem-solving therapy is a tool that teaches structured ways to address current problems or challenges in your life. Participants who are assigned to receive problem-solving therapy will work with a research team member for six, one-hour sessions. During each session, participants will identify a problem (big or small) and create a plan to work on that problem. Participants who are assigned to receive stroke-related health education will work with a research team member who will teach them about various topics related to stroke over six, one-hour sessions. Each session will cover information about a different topic related to stroke. Outcomes data will be collected at approximately 4 weeks, 8 weeks, and 13 weeks from baseline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04035681
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Problem-Solving Therapy
Trials testing the same drug.
- NCT04867122 — Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care · NA · completed
- NCT03473535 — BEACON Suicide Prevention in Men Study · NA · unknown
- NCT02161133 — Cognitive Rehabilitation for Gulf War Illness · NA · completed
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Allina Health System trials
Trials by the same sponsor.
- NCT05098431 — Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery · NA · withdrawn
- NCT05295238 — Compass Course: COVID-19 · NA · completed
- NCT05330104 — SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy · NA · completed
- NCT04083690 — Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients · NA · unknown
- NCT03469414 — Manual Wheelchair Speed, Maneuverability, and Endurance and Community Access · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04035681 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Allina Health System
- Last refreshed: 2 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04035681.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing